AMYLOID BETA/A4 PROTEIN PRECURSOR770 (403-407) manufacturers
|
| | AMYLOID BETA/A4 PROTEIN PRECURSOR770 (403-407) Basic information |
| Product Name: | AMYLOID BETA/A4 PROTEIN PRECURSOR770 (403-407) | | Synonyms: | AMyloid b/A4 Protein Precursor770 (403-407);Amyloid β/A4 Protein Precursor770 (403-407), APP770 (403-407);Amyloid beta/A4 Protein Precursor770 (403-407) trifluoroacetate salt;Amyloid β/A4 Protein Precursor??? (403-407);L-Serine, L-arginyl-L-α-glutamyl-L-arginyl-L-methionyl-;Amyloid β/A4 Protein Precursor??? (403-407) trifluoroacetate salt/APP??? (403-407), β-Amyloid / A4 Protein Precursor (APP) (328-332);Amyloid β/A4 Protein Precursor (403-407);Amyloid β/A4 Protein Precursor770 (403-407) | | CAS: | 148914-08-3 | | MF: | C25H47N11O9S | | MW: | 677.78 | | EINECS: | | | Product Categories: | | | Mol File: | 148914-08-3.mol |  |
| | AMYLOID BETA/A4 PROTEIN PRECURSOR770 (403-407) Chemical Properties |
| density | 1.55±0.1 g/cm3(Predicted) | | pka | 2.96±0.10(Predicted) | | Sequence | H-Arg-Glu-Arg-Met-Ser-OH |
| | AMYLOID BETA/A4 PROTEIN PRECURSOR770 (403-407) Usage And Synthesis |
| Uses | RERMS are bioactive peptides produced from the active regions of amyloid-β and A4 protein precursors that promote fibroblast growth and can be used in the study of neurodegenerative diseases[1]. | | References | [1] Ninomiya, et al. "Amino acid sequence RERMS represents the active domain of amyloid beta/A4 protein precursor that promotes fibroblast growth." The Journal of cell biology 121.4 (1993): 879-886. DOI:10.1083/jcb.121.4.879 |
| | AMYLOID BETA/A4 PROTEIN PRECURSOR770 (403-407) Preparation Products And Raw materials |
|